Short-term rivastigmine treatment reduces EEG slow-wave power in Alzheimer patients

Neuropsychobiology

Volumn 43, Issue 4, 2001, Pages 273-276

  Adler, Georg ^a   Brassen, Stefanie ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Acetylcholinesterase inhibitor; Alzheimer's disease; Dementia; EEG; Rivastigmine; Therapy

Indexed keywords

CHOLINESTERASE INHIBITOR; RIVASTIGMINE;

ADULT; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFECT; FEMALE; FUNCTIONAL DISEASE; HEMISPHERE; HUMAN; MALE; PRIORITY JOURNAL; SHORT COURSE THERAPY; SLOW BRAIN WAVE;

AGED; ALZHEIMER DISEASE; CARBAMATES; CHOLINESTERASE INHIBITORS; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; NEUROPROTECTIVE AGENTS; PHENYLCARBAMATES; PSYCHIATRIC STATUS RATING SCALES;

EID: 0034998049     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054902     Document Type: Article

References (33)

1. Brenner RP, Ulrich RF, Spiker DG, Scabassi RJ, Reynolds CF, Marin RS, Boller F: Computerized EEG spectral analysis in elderly normal, demented and depressed subjects. Electroencephalogr Clin Neurophysiol 1986;64:483-492.
2. Breslau J, Starr A, Sicotte N, Buchsbaum MS: Topographic EEG changes with normal aging and SDAT. Electroencephalogr Clin Neurophysiol 1989;72:281-289.
3. Chiaramonti R, Muscas GC, Paganini M, Müller TJ, Fallgatter AJ, Versari A, Strik WK: Correlations of topographical EEG feature with clinical severity in mild and moderate dementia of Alzheimer type. Neuropsychobiology 1997;36:153-158.
4. Coben LA, Danzinger WL, Berg L: Frequency analysis of the resting awake EEG in mild senile dementia of Alzheimer type. Electroencephalogr Clin Neurophysiol 1983;55:372-380.
5. Duffy FH, Albert MS, McAnulty G: Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type. Ann Neurol 1984;16:439-448.
6. Förstl H, Besthorn C, Sattel H, Zerfass R, Geiger-Kabisch C, Schreiter-Gasser U, Hentschel F: Volumetrische Hinrveränderungen und quantitatives EEG bei normalem Altern und Alzheimer-Demenz. Nervenarzt 1996;67:53-61.
7. Giannitrapani D, Collins J, Vassiliadis D: The EEG spectra of Alzheimer's disease. Int J Psychophysiol 1991;10:259-269.
8. Jelic V, Shigeta M, Julin P, Almkvist O, Winblad B, Wahlund L-O: Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment. Dementia 1996;7:314-323.
9. d'Onofrio F, Salvia S, Petretta V, Bonavita V, Rodriguez G, Tedeschi G: Quantified-EEG in normal aging and dementias. Acta Neurol Scand 1996;93:336-345.
10. Penttila M, Partanen VJ, Soininen H, Rickkinen PJ: Quantitative analysis of occipital EEG in different stages of Alzheimer's disease. Electroencephalogr Clin Neurophysiol 1985;60:1-6.
11. Szelies B, Grond M, Herholz K, Kessler J, Heiss WD: Quantitative EEG mapping and PET in Alzheimer's disease. J Neurol Sci 1992; 110:46-56.
12. Dustman RE, LaMarche JA, Cohn NB, Shearer DE, Talone JM: Power spectral analysis and cortical coupling of EEG for young and old normal adults. Neurobiol Aging 1985;6:193-198.
13. Hartikainen P, Soinen H, Partanen J, Helkala EL, Riekkinen P: Agingand spectral analysis of EEG in normal subjects: A link to memory and CSF AChE. Acta Neurol Scand 1992;86:148-155.
14. Szelies B: Brain Mapping zur Darstellung altersabhängiger Veränderungen in Abgrenzung von Demenz. Nervenarzt 1992;63:609-618.
15. Coben LA, Danzinger W, Storandt M: A longitudinal EEG study of mild senile dementia of Alzheimer type: Changes at 1 year and at 2.5 years. Electroencephalogr Clin Neurophysiol 1985;61:101-112.
16. Dierks T, Perisic I, Frölich L, Ihl R, Maurer K: Topography of the quantitative electroencephalogram in dementia of the Alzheimer type: Relation to severity of dementia. Psychiatr Res 1991;40:181-194.
17. Müller TJ, Thome J, Chiaramonti R, Dierks T, Maurer K, Fallgatter AJ, Frölich L, Scheubeck M, Strik WK: A comparison of qEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 1997;247:259-263.
18. Buchan RJ, Nagata K, Yokoyama E, Langman P, Yuya H, Hirata Y, Hatazawa J, Kanno I: Regional correlations between the EEG and oxygen metabolism in dementia of Alzheimer's type. Electroencephalogr Clin Neurophysiol 1997;103:409-417.
19. Ihl R, Dierks T, Martin E-M, Frölich L, Maurer K: Topography of the maximum of the amplitude of EEG frequency bands in dementia of the Alzheimer type. Biol Psychiatry 1996;39: 319-325.
20. Bartus RT, Dean RL, Beer B, Lippa AS: The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;17:408-417.
21. Davies P, Maloney JF: Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976;ii:403.
22. Riekkinen P, Buzsaki G, Riekkinen P Jr, Soininen H, Partanen J: The cholinergic system and EEG slow waves. Electroencephalogr Clin Neurophysiol 1991;78:89-96.
23. Kikuchi M, Wada Y, Nanbu Y, Nakajima A, Tachibana H, Takeda T, Hashimoto T: EEG changes following scopolamine administration in healthy subjects. Neuropsychobiology 1999; 39:219-226.
24. Agnoli A, Martucci N, Manna V, Conti L, Fioravanti M: Effect of cholinergic and anticholinergic drugs on short-term memory in Alzheimer's dementia: A neuropsychological and computerized electroencephalographic study. Clin Neuropharmacol 1983;6:311-323.
25. Alhainen K, Riekkinen PJ: Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy. Acta Neurol Scan 1993; 149 (suppl): 16-21.
26. Gustafson L, Edvinsson L, Dahlgren N, et al: Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow measurement, and EEG. Psychopharmacology 1987; 93:31-35.
27. Jelic V, Dierks T, Amberla K, Almkvist O, Winblad B, Nordberg A: Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease. Neurosci Lett 1998;254:85-88.
28. Minthon L, Gustafson L, Dalfelt G, Hagberg B, Nilsson K, Risberg J, Rosen I, Seiving B, Wendt PE: Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG. Dementia 1993;4:32-42.
29. Rösler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-Bianco P: Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International, randomised controlled trial. BMJ 1999;318:633-640.
30. Folstein MF, Folstein SE, McHugh PR: 'Mini mental state': A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
31. Reisberg B, Ferris SH, de Leon MJ, Crook T: The global deterioration scale of assessment of primary degenerative dementia. Am J Psychiat 1982;139:1136-1139.
32. Katznelson RD (1981): EEG recording, electrode placement, and aspects of generator localization; in Nuñez PL (ed): Electrical fields of the brain. New York, Oxford University Press, 1981.
33. Semlitsch HV, Anderer P, Saletu B, Schuster P, Presslich O: A solution for reliable and valid reduction of ocular artifacts to the P300 ERP. Psychophysiology 1986;23:695-703.